Why the study?
Does a non-fluoroscopic catheter tracking system (Mediguide) reduce radiation exposure compared to CARTO, Cryoballoon, and PVAC in patients undergoing pulmonary vein isolation?
Does a non-fluoroscopic catheter tracking system (Mediguide) reduce radiation exposure compared to CARTO, Cryoballoon, and PVAC in patients undergoing pulmonary vein isolation?
The Mediguide non-fluoroscopic catheter tracking system significantly reduces radiation exposure during pulmonary vein isolation compared to other ablation systems without increasing complications or atrial fibrillation recurrence.
Answers are grounded in this paper and cite their sources.
Mediguide was associated with lower radiation in PVI; leaves open whether RCTs should change practice.
BACKGROUND: A novel non-fluoroscopic catheter tracking system (Mediguide) can be used in combination with a 3D mapping system for atrial fibrillation (AF) ablation. However, the benefit on radiation exposure of the Mediguide system compared to other ablation systems is unknown. METHODS: We retrospectively enrolled consecutive 73 patients (51 men; 59±11 years; 60 paroxysmal AF) undergoing pulmonary vein isolation by the same operator. Radiation time, radiation effective dose, procedure time, AF recurrence after ablation, and procedure-related complications were compared among 4 different ablation systems. RESULTS: Mediguide was used in 16 patients (group A), CARTO™ in 17 (group B), Cryoballoon in 30 (group C), and Multi-electrode Pulmonary Vein Ablation Catheter (PVAC) in 10 (group D). Although procedure time was shorter in patients with Cryoballoon (median 110 [interquartile range 99-120] min) and PVAC (123 [112-146] min) compared to those with Mediguide (181 [168-214] min) and CARTO (179 [160-195] min) (P<0.001), radiation exposure time and effective dose were decreased in patients with Mediguide compared to the other ablation systems (A: 5 [3-6] min; B: 14 [11-16] min; C: 14 [11-18] min; D: 20 [16-24] min, P<0.001 and A: 1.1 [0.8-2.0] mSv; B: 2.5 [1.3-3.8] mSv; C: 2.0 [1.4-2.5] mSv; D: 1.7 [1.4-3.6] mSv, P=0.015, respectively). AF recurrence rates and procedure-related complications were comparable among the 4 groups. CONCLUSION: The Mediguide system reduces radiation exposure compared to other ablation systems without increasing AF recurrence or procedure-related complications.
No takes yet. Share an insight, caveat, or question.
A 2018 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: